Heat Biologics: Surges on positive pre-clinical data from COVID-19 vaccine trial

Scorpius Holdings

29/07/2020 13:17

** Shares of vaccine developer  HTBX.O  rise 42% to $2.9
premarket; set for their best day in a month 
    ** Co says its experimental COVID-19 vaccine showed positive
result in pre-clinical testing in animals  bit.ly/33bJEg9 
    ** Testing demonstrated expansion of antibody-supporting
CD4+, and virus killing CD8+ T-cells in the lungs of the animals
- HTBX 
    ** Up to Tuesday's close, stock grew more than four-fold
this year

 (Reporting by Dania Nadeem in Bengaluru)
 ((Dania.Nadeem@thomsonreuters.com; within U.S. +1 646 223 8780,
outside U.S. +91 80 6182 3463;))